| Management number | 233470325 | Release Date | 2026/06/27 | List Price | US$4.48 | Model Number | 233470325 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Millions of children take Ritalin for Attention-Deficit Hyperactivity Disorder. The drug's manufacturer, Novartis, claims that Ritalin is the "solution" to this widespread problem. But hidden behind the well-oiled public-relations machine is a potentially devastating reality: children are being given a drug that can cause the same bad effects as amphetamine and cocaine, including behavioral disorders, growth suppression, neurological tics, agitation, addiction, and psychosis. Talking Back to Ritalin uncovers these and other startling facts and translates the research findings for parents and doctors alike. An advocate for education not medication, Dr. Breggin empowers parents to channel distracted, disenchanted, and energetic children into powerful, confident, and brilliant members of the family and society. Read more
| ASIN | B001KR0AO8 |
|---|---|
| XRay | Not Enabled |
| ISBN13 | 978-0738212104 |
| Edition | Revised |
| Language | English |
| File size | 5.0 MB |
| Page Flip | Not Enabled |
| Publisher | Grand Central Publishing |
| Word Wise | Enabled |
| Print length | 464 pages |
| Accessibility | Learn more |
| Publication date | October 10, 2007 |
| Enhanced typesetting | Not Enabled |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form